TITLE

T cells in peripheral blood after gluten challenge in coeliac disease

AUTHOR(S)
Anderson, R. P.; van Heel, D. A.; J A Tye-Din; Barnardo, M.; Salio, M.; Jewell, D. P.; Hill, A. V. S.
PUB. DATE
September 2005
SOURCE
Gut;Sep2005, Vol. 54 Issue 9, p1217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Current understanding of T cell epitopes in coeliac disease (CD) largely derives from intestinal T cell clones in vitro. I cell clones allow identification of gluten peptides that stimulate T cells but do not quantity their contribution to the overall gluten specific I cell response in individuals with CD when exposed to gluten in vivo. Aims: To determine the contribution of a putative dominant T cell epitope to the overall gliadin T cell response in HLA-DQ2 CD in vivo. Patients: HLA-DQ2+ individuals with CD and healthy controls. Methods: Subjects consumed 20 g of gluten daily for three days. interferon γ (IFN-γ) ELISPOT was performed using peripheral blood mononuclear cells (PBMC) to enumerate and characterise peptide and gliadin specific I cells before and after gluten challenge. Results: in 50/59 CD subjects, irrespective of homo- or heterozygosity for HLA-DQ2, IFN-γ ELISPOT responses for an optimal concentration of A-gliadin 57-73 Q-E65 were between 10 and 1500 per million PBMC, equivalent to a median 51% of the response for a "near optimal" concentration of deamidated gliadin. Whole deamidated gliadin and gliadin epitope specific T cells induced in peripheral blood expressed an intestinal homing integrin (α4β7) and were HLA-DQ2 restricted. Peripheral blood T cells specific for A-gliadin 57-73 Q-E65 are rare in untreated CD but can be predictably induced two weeks after gluten exclusion. Conclusion: in vivo gluten challenge is a simple safe method that allows relevant T cells to be analysed and quantified in peripheral blood by ELISPOT, and should permit comprehensive high throughput mapping of gluten T cell epitopes in large numbers of individuals with CD.
ACCESSION #
18143412

 

Related Articles

  • The cytokine interleukin 21: a new player in coeliac disease? Meresse, Bertrand; Verdier, Julien; Cerf-Bensussan, Nadine // Gut;Jul2008, Vol. 57 Issue 7, p879 

    The article presents a study which focuses on the use of single-nucleotide polymorphisms. In this context, researchers demonstrate that interleukin 21 (IL21) expression is increased in the intestinal mucosa of patients with active coeliac disease (CD) but not that of treated patients. It has...

  • Investigation of the putative immunodominant T cell epitopes in coeliac disease. Ellis, H.J.; Pollock, E.L.; Engel, W.; Fraser, J.S.; Rosen-Bronson, S.; Wieser, H.; Ciclitira, P.J. // Gut;Feb2003, Vol. 52 Issue 2, p212 

    Background: Coeliac disease (CD) is an enteropathy mediated by gluten specific T cells which secrete interferon γ (IFN-γ) when stimulated by gluten peptides presented by HLA-DQ2 or DQ8 molecules. Residues 62-75 of α[sub 2] gliadin have been proposed as the immunodominant epitope in the...

  • Diarrhoea and duodenal disease. Nielsen, Jennifer A.; Weber, James J.; Lager, Donna J. // Gut;Nov2014, Vol. 63 Issue 11, p1736 

    The article presents a case study a 27-year-old Caucasian male with history of diarrhoea, severe abdominal cramping, heartburn and weight loss. Duodenal biopsy morphological examination showed variable villous blunting and an increase in intraepithelial lymphocytes and neutrophils. The article...

  • Celiac disease more prevalent than believed. Saunders, Carol S. // Patient Care;4/15/2000, Vol. 34 Issue 7, p12 

    Reports on a study which shows the prevalence of celiac disease in the United States. Need for physicians to have a high index of suspicion when trying to diagnose the disease; Disease as a genetic disorder characterized by malabsorption of gluten-containing foods; Comparison with European...

  • celiac disease, celiac sprue.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p394 

    An encyclopedia entry for "celiac disease, celiac sprue," which refers to the malabsorption, weight loss, and diarrhea, due to immunological intolerance to dietary wheat products, is presented.

  • Avoiding gluten is a challenge when celiac disease strikes.  // Environmental Nutrition;Jan1998, Vol. 21 Issue 1, p7 

    Provides information about gluten intolerance, an inherited disease that goes by many names, primarily celiac disease. Cause of the disease; Estimated number of people in United States who are affected by the disease; Information on how to detect if a person is afflicted with gluten intolerance.

  • A novel and sensitive method for the detection of T cell stimulatory epitopes of &alph;/β- and γ-gliadin. Spaenij-Dekking, E. H. A.; Kooy-Winkelaar, E. M. C.; Nieuwenhuizen, W. F.; Drijfhout, J. W.; Koning, F. // Gut;Sep2004, Vol. 53 Issue 9, p1267 

    Background: It is now generally accepted that coeliac disease (CD) is caused by inflammatory T cell responses to gluten peptides bound to HLA-DQ2 or -DQ8 molecules. There is overwhelming evidence that CD patients can mount T cell responses to peptides found in both α-gliadin and γ-gliadin...

  • Endocytotic segregation of gliadin peptide 31–49 in enterocytes. Zimmer, Klaus-Peter; Fischer, Ina; Mothes, Thomas; Weissen-Plenz, Gabriele; Schmitz, Martina; Wieser, Herbert; Büning, Jürgen; Lerch, Markus M.; Ciclitira, Paul C.; Weber, Peter; Naim, Hassan Y. // Gut;Mar2010, Vol. 59 Issue 3, p300 

    Objective Coeliac disease (CD) is a multisystemic autoimmune inflammation of the intestinal tract induced by wheat gluten and related cereals in human leucocyte antigen (HLA)-DQ2/8-positive individuals. The molecular mechanisms relevant to oral tolerance induction towards toxic cereals such as...

  • Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays. Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Rajasekaran, John; Pasricha, Pankaj J.; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Snyder, Melissa R.; Jayaraman, Vasanth; Murray, Joseph A. // PLoS ONE;1/29/2016, Vol. 11 Issue 1, p1 

    Background: Most antibodies recognize conformational or discontinuous epitopes that have a specific 3-dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics